Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVRx, Inc.CVRX · Entity 6920 | Director · PRES & CEO | February 27, 2026 | March 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVRx, Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 284,237 |
Ending reported balance
After 2026-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-27 · Grant · Acquired 159,000 · Balance 292,000 F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Row 2 · 2026-03-02 · Sale · Disposed 7,763 · Balance 284,237 F2: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. F3: Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2036-02-26 | Direct | 238,000 |
Reported balance
After 2026-02-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-27 · Grant · Acquired 238,000 · Balance 238,000 F4: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
F2: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.
F3: Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 3, 2026 18:03 UTC | CVRx, Inc. CVRX · Entity 6920 | SaleCommon Stock | 7,763 | $7.90 | $61,348.66 |
DisclosureSEC source: 0001467748-26-000002 · form4-03032026_110335.xml · nonDerivative · entry 2 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 284,237 F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction. F3 · price: Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 18:03 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 238,000 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001467748-26-000002 · form4-03032026_110335.xml · derivative · entry 3 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,000 Underlying: Common Stock · 238,000 shares Expires 2036-02-26 F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 18:03 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 159,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001467748-26-000002 · form4-03032026_110335.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| May 12, 2025 Filed May 12, 2025 19:07 UTC | CVRx, Inc. CVRX · Entity 6920 | PurchaseCommon Stock | 5,000 | $4.84 | $24,200.00 |
DisclosureSEC source: 0001415889-25-012699 · form4-05122025_110541.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,000 Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:13 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 148,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006488 · form4-03042025_090317.xml · derivative · entry 2 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 148,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:13 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantCommon Stock | 98,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006488 · form4-03042025_090317.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| August 05, 2024 Filed Aug 5, 2024 16:56 UTC | CVRx, Inc. CVRX · Entity 6920 | PurchaseCommon Stock | 30,000 | $8.36 | $250,767.00 |
DisclosureSEC source: 0001415889-24-020762 · form4-08052024_080830.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · price: Reflects the weighted average price of 30,000 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 5, 2024 with purchase prices ranging from $8.245 to $8.47 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 16:45 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $8.55 | $0.00 |
DisclosureSEC source: 0001415889-24-020639 · form4-08022024_080824.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2034-07-30 F1 · derivative.exercise_date: Vests as to 25% of the shares on July 31, 2025 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 16:57 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 360,000 | $0.00 Strike: $23.61 | $0.00 |
DisclosureSEC source: 0001415889-24-003769 · form4-02142024_090243.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2034-02-11 F1 · derivative.exercise_date: Vests as to 25% of the shares on February 12, 2025 and as to 1/48th of the shares each month thereafter. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 16:13 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 12,012 | $0.00 Strike: $12.33 | $0.00 |
DisclosureSEC source: 0001415889-23-009359 · form4-06072023_080623.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,012 Underlying: Common Stock · 12,012 shares Expires 2033-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 5, 2024 or the Issuer's 2024 annual meeting of stockholders. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 16:02 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 21,776 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001415889-22-012964 · form4-12232022_091257.xml · derivative · entry 2 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,776 Underlying: Common Stock · 21,776 shares Expires 2032-12-21 F2 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 16:02 UTC | CVRx, Inc. CVRX · Entity 6920 | GrantStock Option (right to buy) · Derivative | 5,246 | $0.00 Strike: $15.78 | $0.00 |
DisclosureSEC source: 0001415889-22-012964 · form4-12232022_091257.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,246 Underlying: Common Stock · 5,246 shares Expires 2032-12-21 F1 · derivative.exercise_date: Vests on the earlier of December 21, 2023 or the Issuer's 2023 annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.